Proteopedia

Pharmaceutical Drug Targets and Diseases: Difference between revisions

← Older editNewer edit →
David Canner (talk | contribs)
7,699 edits
No edit summary
David Canner (talk | contribs)
7,699 edits
No edit summary
Line 162: Line 162:
***[[Treatment_of_Gaucher_disease]]
***[[Treatment_of_Gaucher_disease]]
***[[Molecular_Playground/Velaglucerase|Velaglucerase]]
***[[Molecular_Playground/Velaglucerase|Velaglucerase]]
***[[Disulfide Connectivity of Velaglucerase|Velaglucerase Disulfide Connectivity]]


**Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders
**Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Canner, Thomas J. Stout, Eran Hodis, Wayne Decatur, Alexander Berchansky
Retrieved from "https://proteopedia.openfox.io/w/Pharmaceutical_Drug_Targets_and_Diseases"